GoodRx Leverages Split to Ramp Up Product Innovation and Increase Experiments for Over 10 Million Users

Split enables feature flagging and experimentation capabilities for user interaction, backend system migration, and feature iteration.

REDWOOD CITY, CA — (Nasdaq – January 9, 2019) – Split, the leading platform for feature experimentation, today announced that GoodRx, a service that tracks prescription drug prices and offers drug coupons in the U.S., has selected Split to accelerate feature iteration and support sophisticated product experimentation to improve conversions and user adoption for its desktop and mobile application.

GoodRx’s real-time, market-intelligence platform gathers retail prices and coupons for every FDA-approved medication, at more than 70,000 pharmacies across the U.S., providing savings of up to 80%. More than 10 million consumers use GoodRx to save on their prescriptions each month. With a growing customer base, GoodRx application teams started conducting A/B tests using an in-house feature flagging solution. With the success of these tests, the team wanted to expand experimentation their practices. However, extending the in-house system to support increasing scale and scope was outside their expertise and siphoned resources away from delivering customer value.

“Split allows GoodRx to implement sophisticated product experiments and offers a frontend experience that helps customers save on prescription medication,” said Eric Wang, Director of Engineering, GoodRx “As a resource to millions for affordable health care, we needed a solution that will remain reliable for our customers and with Split we can do just that and more.”

Split allows GoodRx to centrally track and monitor feature flags and experiments on several applications run by their engineering teams. Split’s intuitive user interface makes it easy to get new features up and running quickly, allowing for frontend and backend feature testing and experimentation that has far-reaching impact on the user. Engineering teams can control the number of users exposed to features while testing new functionality with ease. GoodRx continues to expand their use of the Split platform for its A/B testing and feature iteration capabilities and aims to continue deploying code to help engineers identify problems early to reduce risk and improve productivity.

GoodRx has achieved the following benefits from using Split:

  • 95% reduction in execution time by eliminating the need for a full deploy of their mobile web application at each phase of a rollout
  • Immediacy to kill problematic features without manual intervention or code deploy; and
  • Safe migration of backend systems without impacting user experience.

“We’re thrilled to see the results GoodRx has produced with Split and excited that we have equipped them with the competitive edge they needed to create a more streamlined and user-friendly experience for their users,” said Adil Aijaz, CEO and co-founder at Split.

For more information, download the GoodRx case study here:

To sign up for Split, visit or contact

About Split

Split is the leading product decisions platform for engineering and product teams that want to rapidly – and safely – deliver valuable software to customers. Unlike systems that are homegrown, point solutions, or those not built for engineering and product teams, only Split provides a unified feature flags and experimentation solution that is trusted by engineers and built for teams of any size to make data-driven decisions. Split ingests large volume of data and performs near real-time statistical analysis to look for impact of every feature release on metrics that matter to you. Engineering and product teams at Twilio, Salesforce, and WePay trust Split with their feature management and decisions. To learn more about Split, contact, or get started for free at